Fundraise / allotmentFiled on NSE ·
Osel Devices Limited proposes preferential issue of 1.7 lakh Convertible Warrants at ₹4.12 lakh each
OSEL Devices Ltd · Healthcare Equipment & Supplies
What the filing says
- Board approved preferential issue on October 17, 2026, to Mrs. Pooja Kohli, a non-promoter public allottee
- Total amount to be raised is ₹7.00 crore via fully convertible warrants with premium of ₹4.02 lakh per warrant
- Compliance confirmed with SEBI ICDR Regulations, Companies Act 2013 provisions, and requisite shareholder approval required
Original filing
Shareholders meeting
Read the filing on NSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies Ltd
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from OSEL Devices Ltd
- Fundraise / allotmentNotableOSEL Devices Ltd appoints Strategic Consultant and approves interim dividend, warrants issue
- Fundraise / allotmentNotableOSEL Devices announces interim dividend, warrant issue, and consultant appointment
- Fundraise / allotmentNotableOSEL Devices appoints Kapil Kohli as Strategic Consultant and approves warrant issue
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentNDTVNDTV announces board meeting to consider fund raising via debt securities issuance
- Fundraise / allotmentKiri Industries LtdKiri Industries submits detailed utilisation plan for 60,82,600 convertible warrants issue
- Fundraise / allotmentAffle 3i LtdAffle 3i Limited allots 12.77 lakh shares on warrant conversion to promoter
- Fundraise / allotmentPersistent Systems LtdPersistent Systems approves QIP Issue with floor price of ₹5,550 per share
- Vintage Coffee and Beverages Limited Board approves fund raising and limit enhancements
- OnEMI Technology Solutions gets NSE and BSE in-principle approval for preferential issue
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.